MicroRNA in lung cancer—a novel potential way for early diagnosis and therapy

[1]  Woosun Baek,et al.  From Molecular Mechanisms to Therapeutics: Understanding MicroRNA-21 in Cancer , 2022, Cells.

[2]  Dzmitry G. Shcharbin,et al.  Circulating microRNAs in Medicine , 2022, International journal of molecular sciences.

[3]  Y. Ahmadi,et al.  Circulating microRNAs as predictive biomarkers of coronary artery diseases in type 2 diabetes patients , 2022, Journal of clinical laboratory analysis.

[4]  Qiushi Wang,et al.  Comparison of tumor and two types of paratumoral tissues highlighted epigenetic regulation of transcription during field cancerization in non-small cell lung cancer , 2022, BMC medical genomics.

[5]  M. Maiuri,et al.  Circular RNAs as Potential Biomarkers in Breast Cancer , 2022, Biomedicines.

[6]  O. Chabre,et al.  MicroRNA Therapeutics in Cancer: Current Advances and Challenges , 2021, Cancers.

[7]  Sachin Kumar,et al.  Role of microRNAs in regulating cell proliferation, metastasis and chemoresistance and their applications as cancer biomarkers in small cell lung cancer. , 2021, Biochimica et biophysica acta. Reviews on cancer.

[8]  Iekhsan Othman,et al.  The Role of MicroRNAs in Lung Cancer Metabolism , 2021, Cancers.

[9]  P. Campomenosi,et al.  Measurements Methods for the Development of MicroRNA-Based Tests for Cancer Diagnosis , 2021, International journal of molecular sciences.

[10]  J. Borlak,et al.  miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer. , 2020, Translational research : the journal of laboratory and clinical medicine.

[11]  Dongdong Guo,et al.  Association of MicroRNA-21 with p53 at Mutant Sites R175H and R248Q, Clinicopathological Features, and Prognosis of NSCLC , 2020, Molecular therapy oncolytics.

[12]  G. Che,et al.  Prognostic value of let-7 in lung cancer: systematic review and meta-analysis , 2020, Translational cancer research.

[13]  K. Kelnar,et al.  Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours , 2020, British Journal of Cancer.

[14]  T. Schlange,et al.  Integrating circulating miRNA analysis in the clinical management of lung cancer: Present or future? , 2020, Molecular aspects of medicine.

[15]  N. Alitheen,et al.  The Regulatory Role of MicroRNAs in Breast Cancer , 2019, International journal of molecular sciences.

[16]  T. Schlange,et al.  Multicentric Evaluation of Circulating Plasma MicroRNA Extraction Technologies for the Development of Clinically Feasible Reverse Transcription Quantitative PCR and Next-Generation Sequencing Analytical Work Flows. , 2019, Clinical chemistry.

[17]  P. Kuo,et al.  The Roles of MicroRNA in Lung Cancer , 2019, International journal of molecular sciences.

[18]  J. Shih,et al.  MicroRNA in Lung Cancer Metastasis , 2019, Cancers.

[19]  D M Parkin,et al.  Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods , 2018, International journal of cancer.

[20]  Ana Kozomara,et al.  miRBase: from microRNA sequences to function , 2018, Nucleic Acids Res..

[21]  Yingyong Hou,et al.  Two plasma microRNA panels for diagnosis and subtype discrimination of lung cancer. , 2018, Lung cancer.

[22]  L. Dai,et al.  Lung adenocarcinoma cell-derived exosomal miR-21 facilitates osteoclastogenesis. , 2018, Gene.

[23]  Wei Zhao,et al.  Induction of microRNA-let-7a inhibits lung adenocarcinoma cell growth by regulating cyclin D1 , 2018, Oncology reports.

[24]  G. Lang,et al.  DNA methylation of microRNA‐coding genes in non‐small‐cell lung cancer patients , 2018, The Journal of pathology.

[25]  Hecheng Li,et al.  miRNAs as biomarkers and for the early detection of non-small cell lung cancer (NSCLC). , 2018, Journal of thoracic disease.

[26]  A. Mozzarelli,et al.  Higher expression of miR-133b is associated with better efficacy of erlotinib as the second or third line in non-small cell lung cancer patients , 2018, PloS one.

[27]  S. Fan,et al.  MicroRNAs associated with therapy of non-small cell lung cancer , 2018, International journal of biological sciences.

[28]  Qun Zhou,et al.  MicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non‐small cell lung cancer , 2017, Cell proliferation.

[29]  Min Zhang,et al.  Circulating microRNAs as novel biomarkers of ALK-positive non-small cell lung cancer and predictors of response to crizotinib therapy , 2017, Oncotarget.

[30]  N. Seki,et al.  The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes , 2017, Journal of Human Genetics.

[31]  S. Khan,et al.  miRNA nanotherapeutics for cancer. , 2017, Drug discovery today.

[32]  Yan-Ze Jin,et al.  MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status , 2016, Oncotarget.

[33]  P. Pelicci,et al.  miR-494-3p is a novel tumor driver of lung carcinogenesis , 2016, Oncotarget.

[34]  Dong Sun Kim,et al.  Combined Effect of Metastasis‐Related MicroRNA, miR‐34 and miR‐124 Family, Methylation on Prognosis of Non–Small‐Cell Lung Cancer , 2017, Clinical lung cancer.

[35]  S. Gadgeel,et al.  Predictive and Prognostic Biomarkers in Non-Small Cell Lung Cancer , 2016, Seminars in Respiratory and Critical Care Medicine.

[36]  S. Tenzer,et al.  Paired proteomics, transcriptomics and miRNomics in non-small cell lung cancers: known and novel signaling cascades , 2016, Oncotarget.

[37]  A. Yoshimura,et al.  Clinical relevance of circulating cell-free microRNAs in ovarian cancer , 2016, Molecular Cancer.

[38]  N. Pavlakis,et al.  Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer. , 2016, Epigenomics.

[39]  C. Lawrie,et al.  New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies , 2016, International journal of molecular sciences.

[40]  Rongxia Liao,et al.  Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer , 2016, Tumor Biology.

[41]  W. Roa,et al.  Diagnosing Lung Cancers through Examination of Micro-RNA Biomarkers in Blood, Plasma, Serum and Sputum: A Review and Summary of Current Literature , 2016, International journal of molecular sciences.

[42]  J. Schirren,et al.  Differential miRNA-Expression as an Adjunctive Diagnostic Tool in Neuroendocrine Tumors of the Lung , 2016, Cancers.

[43]  G. Storm,et al.  MicroRNA Targeting to Modulate Tumor Microenvironment , 2016, Front. Oncol..

[44]  M. Zhong,et al.  Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line , 2016, Tumor Biology.

[45]  Hassan Lemjabbar-Alaoui,et al.  Lung cancer: Biology and treatment options. , 2015, Biochimica et biophysica acta.

[46]  M. Garofalo,et al.  microRNAs: An Emerging Paradigm in Lung Cancer Chemoresistance , 2015, Front. Med..

[47]  I. Jurisica,et al.  STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activation , 2015, Oncotarget.

[48]  Massimo Bellomi,et al.  miR-Test: a blood test for lung cancer early detection. , 2015, Journal of the National Cancer Institute.

[49]  Q. Yao,et al.  miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells , 2015, Cancer Gene Therapy.

[50]  Xiumei Li,et al.  The tumor suppressor miR-124 inhibits cell proliferation by targeting STAT3 and functions as a prognostic marker for postoperative NSCLC patients. , 2015, International journal of oncology.

[51]  K. Miyazono,et al.  MicroRNA regulons in tumor microenvironment , 2014, Oncogene.

[52]  Scott M Langevin,et al.  Epigenetics of lung cancer. , 2015, Translational research : the journal of laboratory and clinical medicine.

[53]  O. Fortunato,et al.  Therapeutic Use of MicroRNAs in Lung Cancer , 2014, BioMed research international.

[54]  G. Calin,et al.  Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[55]  B. Jiang,et al.  Alteration in Mir-21/PTEN Expression Modulates Gefitinib Resistance in Non-Small Cell Lung Cancer , 2014, PloS one.

[56]  M. Bhaskaran,et al.  MicroRNAs: history, biogenesis, and their evolving role in animal development and disease. , 2014, Veterinary pathology.

[57]  S. Ren,et al.  MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer. , 2014, Lung cancer.

[58]  R. Knight,et al.  miR-34: from bench to bedside , 2014, Oncotarget.

[59]  A. Segura‐Carretero,et al.  Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo , 2013, Scientific Reports.

[60]  R. Kolde,et al.  Meta‐analysis of microRNA expression in lung cancer , 2013, International journal of cancer.

[61]  S. Fu,et al.  Cell-free Circulating miRNA Biomarkers in Cancer , 2012, Journal of Cancer.

[62]  A. Yoshimura,et al.  MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells , 2012, International journal of oncology.

[63]  Wei Wu,et al.  Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues , 2012, Journal of experimental & clinical cancer research : CR.

[64]  D. Takai,et al.  Genome structure‐based screening identified epigenetically silenced microRNA associated with invasiveness in non‐small‐cell lung cancer , 2012, International journal of cancer.

[65]  Xiao-guang Liu,et al.  miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes , 2012, Journal of Cancer Research and Clinical Oncology.

[66]  Drew M. Pardoll,et al.  The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.

[67]  H. Ji,et al.  miR-375 is highly expressed and possibly transactivated by achaete-scute complex homolog 1 in small-cell lung cancer cells. , 2012, Acta biochimica et biophysica Sinica.

[68]  Simon C Watkins,et al.  Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. , 2012, Blood.

[69]  J. Balko,et al.  A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT , 2011, British Journal of Cancer.

[70]  H. Xia,et al.  MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[71]  C. Croce,et al.  EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers , 2011, Nature Medicine.

[72]  D. Takai,et al.  CpG island methylation of microRNAs is associated with tumor size and recurrence of non‐small‐cell lung cancer , 2011, Cancer science.

[73]  F. Slack,et al.  MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy , 2011, Nature Reviews Cancer.

[74]  G. Calin,et al.  MicroRNAs in body fluids—the mix of hormones and biomarkers , 2011, Nature Reviews Clinical Oncology.

[75]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[76]  Eun Kyung Kim,et al.  Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients. , 2011, Molecular medicine reports.

[77]  Jun Chen,et al.  Clinical significance and the correlation of expression between Let-7 and K-ras in non-small cell lung cancer. , 2010, Oncology letters.

[78]  C. Croce,et al.  Targeting microRNAs in cancer: rationale, strategies and challenges , 2010, Nature Reviews Drug Discovery.

[79]  M. Zhong,et al.  MicroRNAs reduce tumor growth and contribute to enhance cytotoxicity induced by gefitinib in non-small cell lung cancer. , 2010, Chemico-biological interactions.

[80]  E. Wang,et al.  Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells , 2010, BMC Cancer.

[81]  George A Calin,et al.  MicroRNAs and cancer--new paradigms in molecular oncology. , 2009, Current opinion in cell biology.

[82]  Daniel G. Anderson,et al.  Knocking down barriers: advances in siRNA delivery , 2009, Nature Reviews Drug Discovery.

[83]  Anindya Dutta,et al.  MicroRNAs in cancer. , 2009, Annual review of pathology.

[84]  Y. Ishikawa,et al.  A mouse model for EML4-ALK-positive lung cancer , 2008, Proceedings of the National Academy of Sciences.

[85]  S. Ropero,et al.  A microRNA DNA methylation signature for human cancer metastasis , 2008, Proceedings of the National Academy of Sciences.

[86]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[87]  Phillip A Sharp,et al.  Suppression of non-small cell lung tumor development by the let-7 microRNA family , 2008, Proceedings of the National Academy of Sciences.

[88]  Roberto Piva,et al.  The anaplastic lymphoma kinase in the pathogenesis of cancer , 2008, Nature Reviews Cancer.

[89]  Martin J. Simard,et al.  Argonaute proteins: key players in RNA silencing , 2008, Nature Reviews Molecular Cell Biology.

[90]  Shamit Soneji,et al.  Microrna expression distinguishes between germinal center B cell‐like and activated B cell‐like subtypes of diffuse large B cell lymphoma , 2007, International journal of cancer.

[91]  Ying Feng,et al.  Supplemental Data P53-mediated Activation of Mirna34 Candidate Tumor-suppressor Genes , 2022 .

[92]  H. Aburatani,et al.  Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer , 2007, Nature.

[93]  Angela N. Brooks,et al.  Structural Basis for Double-Stranded RNA Processing by Dicer , 2006, Science.

[94]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[95]  Shuta Tomida,et al.  Reduced expression of Dicer associated with poor prognosis in lung cancer patients , 2005, Cancer science.

[96]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[97]  J. M. Thomson,et al.  Argonaute2 Is the Catalytic Engine of Mammalian RNAi , 2004, Science.

[98]  Peter A. Jones,et al.  Epigenetics in human disease and prospects for epigenetic therapy , 2004, Nature.

[99]  B. Cullen,et al.  Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. , 2003, Genes & development.

[100]  V. Kim,et al.  The nuclear RNase III Drosha initiates microRNA processing , 2003, Nature.

[101]  B. Reinhart,et al.  Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA , 2000, Nature.